Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07192757 · ClinicalTrials.gov registry record · NA
Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss
A NA study of Presbycusis, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT07192757: Recruiting NA study of Presbycusis, sponsored by University of Florida.
NCT07192757 is a NA study of Presbycusis that is actively recruiting participants, run by University of Florida. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07192757, a NA study of Presbycusis, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Hearing loss, especially for speech perception in the presence of noise, may lead older individuals to withdraw from social situations. While hearing aids help amplify sound and are useful in many situations, they can be ineffective in noisy contexts. The proposed pilot study will evaluate taVNS for improving speech in noise perception in adults with age-related hearing loss.
Primary Outcome
Percent correct on a speech in noise perception task in participants receiving Treatment A compared to Treatment B
Conditions Studied
Interventions
- DEVICE transcutaneous auricular vagus nerve stimulation
- DEVICE Sham Control
Study Locations (1)
Florida
- UF Health at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What NCT07192757 shows while recruiting
NCT07192757 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Presbycusis appearing as the primary indexed condition, and to 2 interventions - of which transcutaneous auricular vagus nerve stimulation is the first listed.
NCT07192757 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07192757 about?
NCT07192757 is a clinical study titled "Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss". Hearing loss, especially for speech perception in the presence of noise, may lead older individuals to withdraw from social situations. While hearing aids help amplify sound and are useful in many situations, they can be ineffective in noisy contexts. The proposed pilot study will evaluate taVNS for...
What is the current status of trial NCT07192757?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-12-01. Estimated completion is 2026-07-30.
What conditions does trial NCT07192757 study?
This clinical trial studies the following conditions: Presbycusis.
What interventions are being tested in trial NCT07192757?
The interventions under investigation include: transcutaneous auricular vagus nerve stimulation (DEVICE), Sham Control (DEVICE).
Who is sponsoring clinical trial NCT07192757?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07192757 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbycusis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07192757's enrollment target sits among peer trials
36 1542nd of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI